It has to be pointed out that, except for direct klotho administration, each of the mentioned pharmacological compounds is already approved for the use in CKD, and for some but not all of these, positive renal outcome data in humans with CKD are available [157]. This evidence concerns the gene KL and chronic kidney disease.